Avainsana: vaccine

Posted in vauen vaufien

Brussels concludes talks with fifth vaccine manufacturer

The EU concluded exploratory talks with U.S. based company Moderna Monday to purchase a potential vaccine against COVID-19 – the fifth company with which the…

Lue lisää
Posted in csr news en

WHO presses for greater investment in global COVID-19 vaccine facility

Investing in a mechanism that will guarantee all countries have fair and timely access to a COVID-19 vaccine is the only way out of the…

Lue lisää
Posted in Chief editor choice csr news en

New talks with CureVac expand EU portfolio of future vaccines

The EU Commission concluded Thursday exploratory talks with CureVac to purchase a potential vaccine against COVID-19, offering the possibility for all EU Member States to…

Lue lisää
Posted in csr news en

Brussels reaches 1st agreement on potential COVID-19 vaccine

The EU Commission reached first agreement with pharmaceutical company AstraZeneca Friday to buy a potential vaccine against COVID-19 as well as to donate to lower…

Lue lisää
Posted in Chief editor choice vauen vaufien Week's highlights

Will Europe win the race to secure a COVID-19 vaccine?

A total of 31 vaccines are now undergoing human trials, including eight which have moved to phase three, with large-scale efficacy tests. The international, high-stakes…

Lue lisää
Posted in csr news en

WHO keen to review Russian vaccine trials

The World Health Organization said on Wednesday it was looking forward to reviewing clinical trials of a potential coronavirus vaccine developed in Russia. President Vladimir…

Lue lisää
Posted in csr news en

Coronavirus: Germany’s Robert Koch Institute withdraws optimistic vaccine claim

Germany’s top institute for infectious diseases pulled its own paper which claimed a vaccine could be available this fall. The Robert Koch Institute said the…

Lue lisää
Posted in csr news en

Misinformation on social media is a ’growing threat’ to coronavirus vaccine efforts

As the world races to find a vaccine to prevent COVID-19, health officials in the UK are concerned that misinformation about vaccines is spreading. A…

Lue lisää
Posted in Chief editor choice

Once a COVID-19 vaccine is found, what happens next?

Amid talk of vaccine nationalism, news of countries hoarding Covid-19 medication, and vaccine hesitancy, many fail to see the potential good news. Currently, there are…

Lue lisää
Posted in Chief editor choice

Once a COVID-19 vaccine is found, what happens next?

Amid talk of vaccine nationalism, news of countries hoarding Covid-19 medication, and vaccine hesitancy, many fail to see the potential good news. Currently, there are…

Lue lisää
Posted in csr news en

Coronavirus vaccine put to final test in US in thousands of volunteers

A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for Covid-19 at the Kaiser Permanente Washington…

Lue lisää
Posted in csr news en

U.S. drugmaker earnings heat up this week with spotlight on vaccine news

Several major U.S. drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc (PFE.N), Merck & Co (MRK.N) and…

Lue lisää
Posted in vauen vaufien

US doubles spending on potential virus vaccine to nearly $1 billion

The United States has doubled its investment — to nearly $1 billion — to expedite development of a potential COVID-19 vaccine by American firm Moderna,…

Lue lisää
Posted in csr news en

Vaccine could be ready for Christmas, says UK health minister

Britain’s health minister Matt Hancock said on Tuesday that under the ”best-case scenario” a COVID-19 vaccine will be ready for Christmas. Answering questions from the…

Lue lisää
Posted in vauen vaufien

Covid-19 vaccine developed by US biotech firm Moderna enters final stage trial

US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, to test how…

Lue lisää
Posted in csr news en recap en

Coronavirus: Fewer Germans willing to get vaccinated, survey shows

Just over 60% of people in Germany would be willing to get vaccinated against COVID-19, a new survey has found. For researchers, the staunch opponents…

Lue lisää
Posted in csr news en Week's highlights

J&J moves up start of coronavirus vaccine human trials to July

Johnson & Johnson moved up the start of human clinical trials for its experimental vaccine against the highly contagious coronavirus by two months to the…

Lue lisää
Posted in vauen vaufien

Coronavirus vaccine: AstraZeneca boosts potential supply to 2bn

AstraZeneca said it will be able to supply two billion doses of a potential virus vaccine following two new deals. Last month, AstraZeneca said it could…

Lue lisää
Posted in weben

Bill Gates-backed vaccine alliance looks to raise $7.4 billion from world leaders

Global leaders are set to pledge billions of dollars toward vaccination funding on Thursday at a U.K.-hosted summit that aims to raise at least $7.4…

Lue lisää
Posted in csr news en recap en weben Week's highlights

EU wants to borrow $8.5 billion for vaccines, health care

The European Commission has proposed spending billions to help the EU reduce its dependency on foreign medical supplies. It said nations need to address ”vulnerabilities”…

Lue lisää